(Q51479446)

5 April 2018

review article

1 reference

title

Use of midazolam in the treatment of refractory status epilepticus. (English)

1 reference

5 April 2018

1 reference

1 reference

Hanley DF

1

1 reference

5 April 2018

Kross JF

series ordinal

2

1 reference

5 April 2018

publication date

1 November 1998

1 reference

5 April 2018

published in

Clinical Therapeutics

1 reference

5 April 2018

volume

20

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

1093-1105

1 reference

5 April 2018

Refractory status epilepticus in adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Recognizing and classifying epileptic seizures and epileptic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Status epilepticus in children, adults, and the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Advances in the management of refractory status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

1 reference

7 January 2021

Convulsive status epilepticus in children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Generalized convulsive status epilepticus in the adult

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Status epilepticus: mechanisms of brain damage and rational management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Treatment of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

1 reference

7 January 2021

Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Midazolam: an effective intravenous agent for seizure control

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Treatment of refractory generalized status epilepticus with continuous infusion of midazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Unilateral limbic epileptic status activity: stereo EEG, behavioral, and cognitive data

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Use of intravenous midazolam in status epilepticus in children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Midazolam for treatment of refractory neonatal seizures. A case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

A comparison of rectal diazepam gel and placebo for acute repetitive seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

IM midazolam for status epilepticus in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

A pharmacodynamic evaluation of midazolam as an antiepileptic compound

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Propofol in the management of refractory status epilepticus: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Seizures associated with propofol anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Dose of midazolam should be reduced during diltiazem and verapamil treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

Midazolam infusion for basal sedation in intensive care: absence of accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980106-9

7 January 2021

10.1016/S0149-2918(98)80106-9

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018